Irish blogger Leonie Fennell has a fascinating post up regarding the SSRi Prozac [fluoxetine]
Her post focuses on a recently released video where Dr. John Virapen, who worked in the pharmaceutical industry for over 35 years, opens the seedy door to the psychiatric and pharmaceutical industry.
Leonie writes:
"I bribed the Swedish Government to get the licence for Prozac". These are the words of Dr. John Virapen who worked in the pharmaceutical industry for over 35 years. I have written about Dr. Virapen before because he told me about the corruption he got up to when he worked for Lundbeck. Anyway before he was employed by Lundbeck he worked for Eli-Lilly who are the manufacturers of Prozac. He refers to bribing Swedish officials because Eli-Lilly told him his job depended on it. He also says that the pharmaceutical industry have been buying doctors, picking them up in medical scool and paying their tuition to influence their prescribing.
He was at one stage in charge of a clinical study for Prozac in one of the largest hospitals in Stockholm. The first week of the trial two of the volunteers tried to commit suicide which he admits is a major side-effect of ssri medication.
He says that the pharmaceutical industry is now trying to target children with these drugs, Strattera, Prozac, Ritalin, Paxil, Zoloft, Ect. and that hand picked psychiatrists, paid for by the pharma industry, meet once a year to come up with new "disorders".
He says in one year 157 people were either killed or seriously injured by Strattera, among the victims was a 3 year old girl.
The video, which I have just watched from start to finish, is something that all readers of this blog should watch. It's a fascinating insight into the world of the psychopharmaceutical monopoly.
Leonie's post can be read HERE
In the meantime, take out 38 minutes of your time and watch this revealing video.
Fid
ORDER THE PAPERBACK
'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman
US & CANADA HERE OR UK FROM CHIPMUNKA PUBLISHING
AUSTRALIAN ORDERS HERE
No comments: